PHAN CHAU TRINH UNIVERSITY
PHAN CHAU TRINH UNIVERSITY
Tuyển Sinh Đại Học
Admissions 2024
Connect via Zalo:
0962 553 155 - 0981 559 255

Contact Admission

Email Us:
Call Us:
+84 0981 559 255
Send your documents:
09 Nguyen Gia Thieu Street, Dien Ngoc Ward, Dien Ban Town, Quang Nam Province, Vietnam
Follow Us on Social Media
Follow us on social media for tips, news and updates about appling to Phan Chau Trinh University:

Online First

Trouble viewing this email? Read it Online
 JAMA Dermatology Online First: Read new online first articles from JAMA Dermatology, a publication of the JAMA Network. Advertisement
JAMA Dermatology masthead

Online First

 DECEMBER 7, 2022
facebook icon twitter icon linked in icon pinterest icon youtube icon instagram icon

ORIGINAL INVESTIGATION

Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients

Anastasia Dupré, MD; Nathalie Morel, MD; Cécile Yelnik, MD; et al.

JAMA DERMATOLOGY CLINICOPATHOLOGICAL CHALLENGE

Intensively Pruritic Annular Papules on the Extremities of a Middle-aged Woman

Yanan Wang, MD; Yueping Zeng, MD

Earn CME credit

RESEARCH LETTER

Association Between Metastatic Melanoma Response to Checkpoint Inhibitor Therapy and Tumor-Infiltrating Lymphocyte Classification on Primary Cutaneous Melanoma Biopsies

Michael R. Stephens, MD; Oyinade Aderbigbe, MD; Wei Xu, MBE; et al.

CORRECTION

Clarification of Conflict of Interest Disclosures

CLINICAL CHALLENGE – CME FROM JN LEARNING™

Multiple Yellowish Plaques in a Cobblestone Pattern on the Tongue

  1. Verrucous xanthoma
  2. Colloid milium–classic adult type
  3. Nodular amyloidosis
  4. Nodular colloid degeneration
What Is Your Diagnosis?

TRENDING NOW ON JAMA DERMATOLOGY

Nutritional Supplementation for Hair Loss

Assessment of Blue Light Phototherapy for Grover Disease: A Nonrandomized Controlled Trial

Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population

Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus

Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis

Join the conversation. Follow JAMA Dermatology on Twitter.
JAMA Network signature

Thank you for subscribing to JAMA Network email alerts. This message was sent to buiduytam1@gmail.com by updates@jamanetwork.org.

To update your contact information, change your email preferences, or unsubscribe, click here.

To ensure you always receive JAMA Network emails, add the email address updates@jamanetwork.org to your address book.

To unsubscribe by mail, contact:

JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.
facebook icon twitter icon linked in icon pinterest icon youtube icon instagram icon

©2022 American Medical Association. All rights reserved.
 
JAMA Network Advertisement
 

Other library

PCTU pctu Hội nghị khoa học